Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q2)Oct 31, 2025 | (Q1)Jul 31, 2025 | (FY)Apr 30, 2025 | (Q4)Apr 30, 2025 | (Q3)Jan 31, 2025 | (Q2)Oct 31, 2024 | (Q1)Jul 31, 2024 | (FY)Apr 30, 2024 | (Q4)Apr 30, 2024 | (Q3)Jan 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 18.46%3.58M | 20.15%928.28K | -19.56%3.54M | -145.87%-766.11K | -34.57%509.31K | 236.59%3.02M | -26.57%772.59K | 154.28%4.4M | 40.69%1.67M | 164.30%778.37K |
| Selling and administrative expenses | 33.32%3.39M | 22.39%622.28K | -28.52%1.88M | -289.08%-1.52M | -29.27%355.14K | 317.09%2.54M | -29.27%508.46K | 83.46%2.63M | -18.63%804.26K | 101.04%502.09K |
| -General and administrative expense | 33.32%3.39M | 22.39%622.28K | -28.52%1.88M | -289.08%-1.52M | -29.27%355.14K | 317.09%2.54M | -29.27%508.46K | 83.46%2.63M | -21.87%804.26K | 132.24%502.09K |
| Research and development costs | ---- | 57.38%162.71K | 74.68%575.52K | 28.65%124.97K | -13.53%67.39K | 259.89%279.78K | 34.86%103.38K | 151.50%329.47K | --97.14K | --77.93K |
| Other operating expenses | -59.78%193.98K | 15.85%306K | -6.20%1.66M | -12.87%754.56K | -44.20%154.17K | 66.93%482.34K | -20.74%264.13K | 500.01%1.76M | 335.56%866.06K | 517.34%276.28K |
| Operating profit | -18.46%-3.58M | -20.15%-928.28K | 19.56%-3.54M | 145.87%766.11K | 34.57%-509.31K | -236.59%-3.02M | 26.57%-772.59K | -154.28%-4.4M | -40.69%-1.67M | -164.30%-778.37K |
| Net non-operating interest income (expenses) | -24.56K | -25.95K | 31.31%-101.1K | 0 | 0 | -578.30%-147.19K | ||||
| Non-operating interest income | --2.97K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Non-operating interest expense | --27.54K | --25.95K | -31.31%101.1K | ---- | ---- | --0 | --0 | 578.30%147.19K | ---- | ---- |
| Other net income (expenses) | -1.64%842.97K | 100.01%394 | -26,629.41%-5.61M | -410,875.08%-2.62M | -57.54%-6.41K | 8,025.91%857.03K | -70,129.28%-3.84M | 99.85%-20.99K | 99.96%-638 | 99.97%-4.07K |
| Gain on sale of security | -311.20%-15.93K | 773.03%4.52K | --3.19K | --9.88K | ---2.15K | ---3.87K | ---671 | ---- | ---- | ---- |
| Special income (charges) | -100.48%-4.16K | 99.89%-4.12K | -26,644.59%-5.61M | -412,423.98%-2.63M | -4.67%-4.26K | 8,061.74%860.9K | -70,117.00%-3.84M | 99.85%-20.99K | 99.96%-638 | 99.97%-4.07K |
| -Less:Restructuring and mergern&acquisition | 100.48%4.16K | -99.89%4.12K | 22,870.53%5.61M | 64,312.70%2.63M | 4.67%4.26K | -8,061.74%-860.9K | 70,117.00%3.84M | -99.81%24.43K | -99.31%4.09K | -99.97%4.07K |
| -Less:Write off | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 96.47%-3.45K | ---- | ---- |
| Other non-operating income (expenses) | --863.07K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Income before tax | -27.55%-2.76M | 79.31%-953.84K | -102.52%-9.25M | -7.64%-1.96M | 34.09%-515.73K | -138.28%-2.17M | -335.96%-4.61M | 70.68%-4.57M | 38.67%-1.82M | 93.65%-782.44K |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | -27.55%-2.76M | 79.31%-953.84K | -102.52%-9.25M | -7.64%-1.96M | 34.09%-515.73K | -138.28%-2.17M | -335.96%-4.61M | 70.68%-4.57M | 38.67%-1.82M | 93.65%-782.44K |
| Net income continuous operations | -27.55%-2.76M | 79.31%-953.84K | -102.52%-9.25M | -7.64%-1.96M | 34.09%-515.73K | -138.28%-2.17M | -335.96%-4.61M | 70.68%-4.57M | 38.67%-1.82M | 93.65%-782.44K |
| Noncontrolling interests | 13.20%-70.71K | -43.34%-63.41K | 26.64%-354.48K | -81.46K | -44.24K | -239.47%-483.21K | ||||
| Net income attributable to the company | -29.14%-2.69M | 80.50%-890.42K | -117.80%-8.89M | -20.05%-1.6M | 34.09%-515.73K | -129.31%-2.08M | -331.78%-4.57M | 73.54%-4.08M | 52.70%-1.33M | 93.65%-782.44K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -29.14%-2.69M | 80.50%-890.42K | -117.80%-8.89M | -20.05%-1.6M | 34.09%-515.73K | -129.31%-2.08M | -331.78%-4.57M | 73.54%-4.08M | 52.70%-1.33M | 93.65%-782.44K |
| Diluted earnings per share | 33.33%-0.02 | 87.50%-0.01 | -50.00%-0.12 | 50.00%-0.01 | 50.00%-0.01 | -50.00%-0.03 | -300.00%-0.08 | 89.19%-0.08 | 71.43%-0.02 | 95.45%-0.02 |
| Basic earnings per share | 33.33%-0.02 | 87.50%-0.01 | -50.00%-0.12 | 50.00%-0.01 | 50.00%-0.01 | -50.00%-0.03 | -300.00%-0.08 | 89.19%-0.08 | 71.43%-0.02 | 95.45%-0.02 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.